What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.46%Below 5Y avg (1.51%)
Annual Rate
TRY 0.59Paid annual
Payout Ratio
15.9%Sustainable
Payback Period
57.7 yr
Last Ex-Dividend
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
120.89BTRY
2.43B · vs all stocks (USD)
Updated Sep 23, 2026
Trailing P/E
10.92x
vs Conglomerates peers
Updated Sep 23, 2026
Revenue (TTM)
213.72BTRY
4.30B · vs all stocks (USD)
Updated Sep 23, 2026
Profit Margin
4.67%
vs Conglomerates peers
Updated Sep 23, 2026
Beta
-0.0390x
vs all stocks
Updated Sep 23, 2026
52-Week Change
1.76%
vs all stocks
Updated Sep 23, 2026
Market Capitalization
120.89BTRY
2.43B · vs all stocks (USD)
Updated Sep 23, 2026
Enterprise Value
272.19BTRY
5.48B · vs all stocks (USD)
Updated Sep 23, 2026
Trailing P/E
10.92x
vs Conglomerates peers
Updated Sep 23, 2026
Forward P/E
3.81x
vs Conglomerates peers
Updated Sep 23, 2026
PEG Ratio
0.3243x
vs Conglomerates peers
Updated Sep 23, 2026
Price to Sales (TTM)
0.5660x
vs Conglomerates peers
Updated Sep 23, 2026
Price to Book (MRQ)
0.3667x
vs Conglomerates peers
Updated Sep 23, 2026
Enterprise to Revenue
1.27x
vs Conglomerates peers
Updated Sep 23, 2026
Enterprise to EBITDA
22.39x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 4.35×.Updated Sep 23, 2026
Gross Margin
25.76%
vs Conglomerates peers
Updated Sep 23, 2026
Profit Margin
4.67%
vs Conglomerates peers
Updated Sep 23, 2026
Operating Margin
-3.36%
vs Conglomerates peers
Updated Sep 23, 2026
Return on Assets (TTM)
-0.43%
vs Conglomerates peers
Updated Sep 23, 2026
Return on Equity (TTM)
3.21%
vs Conglomerates peers
Updated Sep 23, 2026
Revenue (TTM)
213.72BTRY
4.30B · vs all stocks (USD)
Updated Sep 23, 2026
Revenue per Share (TTM)
78.49TRYUpdated Sep 23, 2026
Quarterly Revenue Growth
-12.40%
vs Conglomerates peers
Updated Sep 23, 2026
Gross Profit (TTM)
59.18BTRY
1.19B · vs all stocks (USD)
Updated Sep 23, 2026
EBITDA (TTM)
62.52BTRY
1.26B · vs all stocks (USD)
Updated Sep 23, 2026
Net Income (TTM)
9.98BTRY
200.92M · vs all stocks (USD)
Updated Sep 23, 2026
Quarterly Earnings Growth (YoY)
-4.40%
vs Conglomerates peers
Updated Sep 23, 2026
Operating Cash Flow (TTM)
16.30BTRY
328.05M · vs all stocks (USD)
Updated Sep 23, 2026
Levered Free Cash Flow (TTM)
-56.54BTRY
-1.14B · vs all stocks (USD)
Updated Sep 23, 2026
Trailing Annual Dividend Rate
0.5876TRYUpdated Sep 23, 2026
Trailing Annual Dividend Yield
1.46%
vs all stocks
Updated Sep 23, 2026
5-Year Average Dividend Yield
1.51%
vs all stocks
Updated Sep 23, 2026
Payout Ratio
15.90%
vs Conglomerates peers
Updated Sep 23, 2026
Minority Interest (Equity)
26.69BTRYFY2025 · Dec 31, 2025
Revenue
224.53BTRYFY2025 · Dec 31, 2025
Cost of Goods Sold
162.54BTRYFY2025 · Dec 31, 2025
Gross Profit
61.98BTRYFY2025 · Dec 31, 2025
Operating Income
-77.62MTRY
-1.56M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
12.09BTRYFY2025 · Dec 31, 2025
Income Tax Expense
2.55BTRYFY2025 · Dec 31, 2025
Net Income
9.54BTRYFY2025 · Dec 31, 2025
EBIT
40.06BTRYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
62.52BTRYFY2025 · Dec 31, 2025
Research & Development
1.69BTRYFY2025 · Dec 31, 2025
Selling, General & Administrative
58.86BTRYFY2025 · Dec 31, 2025
Other Operating Expenses
5.16BTRYFY2025 · Dec 31, 2025
Non-operating Interest Income
14.77BTRYFY2025 · Dec 31, 2025
Non-operating Interest Expense
27.96BTRYFY2025 · Dec 31, 2025
EPS (Basic)
3.54TRYFY2025 · Dec 31, 2025
EPS (Diluted)
3.54TRYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.79BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.79BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
9.54BTRYFY2025 · Dec 31, 2025
Minority Interests (P&L)
333.23MTRYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025
Operating Cash Flow
30.75BTRYFY2025 · Dec 31, 2025
Free Cash Flow
1.75BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
38.11BTRYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
9.54BTRYFY2025 · Dec 31, 2025
Other Non-cash Items
9.46BTRYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
2.10BTRYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
9.65BTRYFY2025 · Dec 31, 2025
Capital Expenditures
-29.01BTRYFY2025 · Dec 31, 2025
Net Acquisitions
-14.24BTRYFY2025 · Dec 31, 2025
Purchase of Investments
-1.49BTRYFY2025 · Dec 31, 2025
Other Investing Activity
2.56BTRYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-42.17BTRYFY2025 · Dec 31, 2025
Long-term Debt Issuance
69.35BTRYFY2025 · Dec 31, 2025
Long-term Debt Payments
-65.28BTRYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.63BTRYFY2025 · Dec 31, 2025
Net Financing Cash Flow
1.44BTRYFY2025 · Dec 31, 2025
Shares Outstanding
2.99BSharesUpdated Sep 23, 2026
Float Shares
989.67MSharesUpdated Sep 23, 2026
% Held by Insiders
59.78%
vs all stocks
Updated Sep 23, 2026
% Held by Institutions
3.66%
vs all stocks
Updated Sep 23, 2026
Total Cash (MRQ)
28.41BTRY
571.80M · vs all stocks (USD)
Updated Sep 23, 2026
Total Cash per Share (MRQ)
11.60TRYUpdated Sep 23, 2026
Total Debt (MRQ)
171.63BTRY
3.45B · vs all stocks (USD)
Updated Sep 23, 2026
Total Debt to Equity (MRQ)
0.5718x
vs Conglomerates peers
Updated Sep 23, 2026
Current Ratio (MRQ)
1.81x
vs Conglomerates peers
Updated Sep 23, 2026
Book Value per Share (MRQ)
110.23TRYUpdated Sep 23, 2026
Total Assets
506.93BTRY
10.20B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
141.49BTRYFY2025 · Dec 31, 2025
Total Liabilities
237.67BTRYFY2025 · Dec 31, 2025
Total Non-current Assets
365.44BTRYFY2025 · Dec 31, 2025
Total Non-current Liabilities
125.37BTRYFY2025 · Dec 31, 2025
Total Current Liabilities
112.31BTRYFY2025 · Dec 31, 2025
Cash
8.56BTRYFY2025 · Dec 31, 2025
Cash Equivalents
29.59BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
38.15BTRYFY2025 · Dec 31, 2025
Other Short-term Investments
2.99BTRYFY2025 · Dec 31, 2025
Accounts Receivable
39.98BTRYFY2025 · Dec 31, 2025
Inventory
50.72BTRYFY2025 · Dec 31, 2025
Accounts Payable
31.97BTRYFY2025 · Dec 31, 2025
Short-term Debt
63.17BTRYFY2025 · Dec 31, 2025
Other Current Liabilities
302.53MTRYFY2025 · Dec 31, 2025
Long-term Debt
98.75BTRYFY2025 · Dec 31, 2025
Other Non-current Liabilities
263.87MTRYFY2025 · Dec 31, 2025
Common Stock (Book)
3.06BTRYFY2025 · Dec 31, 2025
Retained Earnings
207.15BTRYFY2025 · Dec 31, 2025
Total Shareholders' Equity
269.26BTRY
5.42B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
5.83BTRYFY2025 · Dec 31, 2025
52-Week Low
32.44TRYUpdated Sep 23, 2026
52-Week High
54.10TRYUpdated Sep 23, 2026
52-Week Change
1.76%
vs all stocks
Updated Sep 23, 2026
Beta
-0.0390x
vs all stocks
Updated Sep 23, 2026
50-Day MA
41.63TRYUpdated Sep 23, 2026
200-Day MA
43.56TRYUpdated Sep 23, 2026
Avg 10-Day Volume
106.22MSharesUpdated Sep 23, 2026
Avg 30-Day Volume
83.95MSharesUpdated Sep 23, 2026
Diluted EPS (TTM)
3.70TRYUpdated Sep 23, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.65: grey zoneSignificant
Altman Z-Score: 1.65
High earnings qualityNotable
Earnings Quality Score: 1.08
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Levered free cash flow is -$1.14B, lower than 95% of all stocks globallySignificant